Considerations for the optimization of in vitro models of chloropicrin toxicity

被引:0
|
作者
Bailey T. Chalmers
Abigail F. Merriman
Albert L. Ruff
机构
[1] US Army Medical Research Institute of Chemical Defense,
来源
Archives of Toxicology | 2023年 / 97卷
关键词
Chloropicrin; Volatility; Cell viability; Toxicity;
D O I
暂无
中图分类号
学科分类号
摘要
Chloropicrin (CP) is a common agricultural fumigant historically used as a chemical warfare agent and is a concern for potential use in warfare and terrorist applications. Our inability to effectively treat CP-induced injuries makes it essential to better understand CP toxicity. We set out to elucidate variables that must be understood to achieve optimal exposure conditions for in vitro investigations given that such models are important for the study of CP injury and potential therapeutics. To this end, we evaluated the effects of volatility, cell seeding density, and serum concentration of cell culture medium on CP toxicity in an immortalized human corneal epithelial cell line. We found that even with very dilute solutions, CP remained highly volatile, so much so that a 0.0019% CP solution resulted in 90% cell death at time 0, but was nearly nontoxic 45 min later. Not surprisingly, the CP-induced IL-8 response was shown to vary with cell viability in this experiment. After exposure with 0.00115% CP, cells that were 12% confluent experienced over 40% more cell death than cells exposed at 87% confluency. Exposure with the same CP dose in medium containing concentrations of fetal bovine serum (FBS) ranging from 0.1% to 15% exhibited a 17% difference in cell viability. Given that chemical toxicity can be significantly influenced by volatility, cell density, and serum content of cell culture medium, these phenomena should be explored during the development and optimization of toxicant exposure models.
引用
收藏
页码:255 / 261
页数:6
相关论文
共 50 条
  • [1] Considerations for the optimization of in vitro models of chloropicrin toxicity
    Chalmers, Bailey T.
    Merriman, Abigail F.
    Ruff, Albert L.
    ARCHIVES OF TOXICOLOGY, 2023, 97 (01) : 255 - 261
  • [2] Toxicity of Chloropicrin Vapor to Plants and Seeds
    Weinberg, J.
    Amato, M.
    Voltz, D.
    Butala, J.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2010, 29 (01) : 109 - 109
  • [3] In vitro Models for Chemical Toxicity: Review of their Applications and Prospects
    Kyung-Taek Rim
    Toxicology and Environmental Health Sciences, 2019, 11 : 94 - 103
  • [4] In vitro Models for Chemical Toxicity: Review of their Applications and Prospects
    Rim, Kyung-Taek
    TOXICOLOGY AND ENVIRONMENTAL HEALTH SCIENCES, 2019, 11 (02) : 94 - 103
  • [5] Reexamining the acute toxicity of chloropicrin: Comprehensive estimation using in silico methods
    Noga, Maciej
    Jurowski, Kamil
    TOXICOLOGY IN VITRO, 2025, 105
  • [6] Cell lines as in vitro models for drug screening and toxicity studies
    Allen, DD
    Caviedes, R
    Cárdenas, AM
    Shimahara, T
    Segura-Aguilar, J
    Caviedes, PA
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2005, 31 (08) : 757 - 768
  • [7] Insights on in vitro models for safety and toxicity assessment of cosmetic ingredients
    Almeida, Andreia
    Sarmento, Bruno
    Rodrigues, Francisca
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 519 (1-2) : 178 - 185
  • [8] Development of mouse models for the study of chloropicrin and hydrogen fluoride ocular injury
    Causey, Robert D.
    Koenig, Jeffrey A.
    Autrey, Jeffrey J.
    McGowan, Kevin J.
    Gomez, Amber M.
    Lehman, John G., III
    Ruff, Albert L.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1479 (01) : 65 - 74
  • [9] Assessment of biosafety and toxicity of hydrophilic gel for implantation in experimental in vitro and in vivo models
    N. Bezdieniezhnykh
    A. Lykhova
    T. Kozak
    T. Zadvornyi
    T. Borikun
    O. Voronina
    N. Lukianova
    BMC Pharmacology and Toxicology, 23
  • [10] Assessment of biosafety and toxicity of hydrophilic gel for implantation in experimental in vitro and in vivo models
    Bezdieniezhnykh, N.
    Lykhova, A.
    Kozak, T.
    Zadvornyi, T.
    Borikun, T.
    Voronina, O.
    Lukianova, N.
    BMC PHARMACOLOGY & TOXICOLOGY, 2022, 23 (01)